Has Vesna Skul received payments from drug or device companies?

Yes. Drug and device makers reported $2,373 in general payments to Vesna Skul across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vesna Skul did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vesna Skul come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vesna Skul

Internal Medicine · Chicago, ILNPI 1134223852

Payments from drug & device makers

$2,373in general payments, 2019–2025

Across 97 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$786
Lilly USA, LLC$300
Amgen$180
Medtronic$158
Teva Pharmaceuticals USA, Inc.$152
Arbor Pharmaceuticals, Inc.$147
plus $650 from 14 others

What the payments were for

Food & beverage$2,26295%
Education$1115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	27	$786
Lilly USA, LLC	16	$300
Amgen	11	$180
Medtronic	1	$158
Teva Pharmaceuticals USA, Inc.	4	$152
Arbor Pharmaceuticals, Inc.	8	$147
Takeda Pharmaceuticals U.S.A., Inc.	8	$141
Radius Health, Inc.	2	$140
Novo Nordisk	2	$49
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$47
Dynavax Technologies Corporation	2	$40
Azurity Pharmaceuticals, Inc.	2	$40
Alfasigma USA, Inc.	2	$39
Therapeuticsmd, Inc.	2	$37
Pfizer	2	$35
Neurocrine Biosciences, Inc.	1	$23
Exact Sciences	1	$18
Shield Therapeutics Inc	1	$15
AMAG Pharmaceuticals, Inc.	1	$14
Ironwood Pharmaceuticals, Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTERSTIM$158
Tymlos$123
NATRELLE SALINE-FILLED BREAST IMPLANTS$120

How this compares

$2,373 in reported general payments places this provider in the 85th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Liothyronine Sodium	14	$1,047
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide	12	$558
Levothyroxine Sodium	27	$525
Gabapentin	18	$352
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$240
Atorvastatin Calcium	28	$227
Allopurinol	12	$205
Hydrochlorothiazide	13	$201

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chicago

Dennis LevinsonChicago$25.3M
Danny SugimotoChicago$4M
Peter O DonnellChicago$3.9M
Daniel CatenacciChicago$3.5M
Patricia WalshChicago$2.1M
Merle DiamondChicago$1.7M
Mohammed KassemChicago$1.3M
David BakerChicago$1M
Azazuddin AhmedChicago$912K
Daniel BergerChicago$861K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →